A user facility clinical manager (cm) reported that a dialyzer blood leak occurred 5 minutes after the initiation of the patient¿s hemodialysis (hd) treatment.The blood leak was noted as being an internal blood leak that could be visually observed at the arterial head of the dialyzer.The machine, a fresenius 2008t machine, alarmed appropriately with a blood leak alarm.Blood leak test strips were used and tested positive for the presence of blood.There was no defect or damage noted on the dialyzer.The patient¿s estimated blood loss (ebl) was approximately 300 ml.There was no patient injury or medical intervention required as a result of this event.The patient opted to end treatment for the day.The complaint device was reported to be unavailable to be returned to the manufacturer for evaluation.
|
Plant investigation: the complaint device was not returned for evaluation however two photographs were provided by the clinic.One photograph depicts a dialyzer label and blood present within the dialyzer, on the outside of the fibers.The second photograph depicts an up-close view of a header end cap with what appears to be blood within the header cap and lower bell housing (indicative of an internal leak).Potential causes of internal blood leaks may be due to damaged/broken fiber(s) or an incomplete seal in the potting material.Probable causes for damaged/broken fibers to occur may be related to the handling of the fiber bundle during production and during the insertion process of the fiber bundle into the dialyzer housing; and incomplete seals in the potting material may be caused by how the dialyzers are loaded into the potting carrousel, potting ratios, and conditioning carrousel media issues, or rough handling.The photographs confirm the reported issue however a cause cannot be determined without evaluation of the complaint device.A production records review was performed on the reported lot.An investigation of the device history records (dhr) was conducted by the manufacturer.There was one approved temporary deviation notice (dn) reported on the lot which was unrelated to the complaint event.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.Continuous improvement is of the utmost importance to fresenius medical care as we strive to provide dialysis products of the highest quality to our patients.Reports of leaking product are investigated both individually as complaints, as well as via the nc/capa program.Capas for vision systems and blood leak reduction are recent examples of leak related investigations directed at an overall reduction in dialyzer leaks.
|
A user facility clinical manager (cm) reported that a dialyzer blood leak occurred 5 minutes after the initiation of the patient¿s hemodialysis (hd) treatment.The blood leak was noted as being an internal blood leak that could be visually observed at the arterial head of the dialyzer.The machine, a fresenius 2008t machine, alarmed appropriately with a blood leak alarm.Blood leak test strips were used and tested positive for the presence of blood.There was no defect or damage noted on the dialyzer.The patient¿s estimated blood loss (ebl) was approximately 300 ml.There was no patient injury or medical intervention required as a result of this event.The patient opted to end treatment for the day.The complaint device was reported to be unavailable to be returned to the manufacturer for evaluation.
|